Nephroblastoma in infants, 1969-75: variations in treatment and survival C A STILLER, E L LENNOX Summary and conclusions In a series of 79 infants aged under 1 year with nephroblastoma diagnosed during 1969-75 all the patients underwent nephrectomy, 33 (42%) received a course of radiotherapy, and 49 (62%) received chemotherapy. The overall three-year survival rate for patients who survived at least one week after diagnosis was 65%. The corresponding rate for infants with stage I tumours was 76%. The survival rate in children with early-stage tumours was significantly higher in those who were treated by nephrectomy and chemotherapy alone compared with those who also received radiotherapy.
In a large proportion of cases nephrectomy and chemotherapy together constituted sufficient treatment for the cure of infants with nephroblastoma, and in some instances nephrectomy alone proved adequate. There was no general tendency for children under 1 year old to be unable to withstand chemotherapy.
Introduction
During 1962-9 in Great Britain the three-year survival rate for children with nephroblastoma aged under 1 year at diagnosis was 450%, while the corresponding rate for children aged 1-15 years was 32% (Childhood Cancer Research Group, unpublished observations). During 1970-3, however, the three-year survival rates for the two age groups were respectively 61 % and 570%.1
Thus the improvement in the rate for children aged over 1 year was substantially greater than that achieved for those aged under 1 year. These very young children were not included in the first MRC Nephroblastoma Study, which was in progress for most of that period, because of their better prognosis and the dangers of cytotoxic chemotherapy at this age. ' We examined records relating to infants diagnosed during 1969-75 to identify groups of patients with a notably better prognosis and to determine whether a higher survival rate was associated with any particular programme of treatment, since the treatment given to infants with nephroblastoma varied considerably.
Patients and methods
During 1969-75, 83 infants resident in Great Britain were notified to the National Cancer Registration Scheme as cases of nephroblastoma. The present series contained 79 infants, whose initial diagnosis of nephroblastoma was histologically confirmed by the hospital pathologist after nephrectomy. The four children not included in the series comprised two in whom the diagnosis was made radiologically and two whose tumours were diagnosed post mortem. Clinical information on all patients was derived from the hospital notes. Follow-up data were provided by the consultants or the patients' general practitioners. All of the children were followed up for at least three years from the time of diagnosis.
Seventy-three of the children had unilateral and six bilateral Table I shows the distribution of children at the time of diagnosis by age and tumour stage. None of the patients in the series presented with distant metastases. In one 3-month-old baby not included in the series, however, postmortem examination showed previously undiagnosed bilateral nephroblastoma with multiple metastases in the liver and both lungs. Four (50) of the 79 children died within one week of diagnosis, the causes of death being renal thrombosis, septicaemia and aspiration pneumonia, pulmonary collapse, and peritonitis and meningitis. These four patients were not included in any analysis of survival rates, as they died too soon for the effects of treatment to be assessed. The proportion of children surviving for three years after diagnosis of nephroblastoma who subsequently die from their disease is extremely small.' 8 We therefore concentrated on three-year survival rates in this report. The pattern of lower survival rates associated with higher-stage unilateral tumours reported in other series of children of all ages with nephroblastoma4 7was repeated in our series.
The three-year survival rate in children under 1 year of age with stage I or II nephroblastoma was 69%. This compares favourably with the rate of 65% in children aged 1 year and over who were diagnosed as having tumours of equivalent stage during 1970-3 and were not included in the MRC Nephroblastoma Study. The rate achieved during the same period within the MRC study in patients with tumours of these stages was 81 %.' This is higher than the 69% survival in our series of children aged under 1 year, an age group which was excluded from the MRC trial because of its better prognosis. The difference in survival rates between patients who were treated by chemotherapy in addition to nephrectomy and those who were treated by nephrectomy alone was not statistically significant. The actual proportion of survivors, however, was higher among the children given chemotherapy. At the very least, it is clear that there was a general tendency for children aged under 1 year to be able to withstand chemotherapy, though no patient aged under two months received this treatment. Among patients with stage I, II, or V tumours, which have a relatively good prognosis, the survival rate was lower in the children given both chemotherapy and radiotherapy than in those given chemotherapy alone. This difference might be accounted for by the perceived need for more intensive treatment for especially aggressive tumours, but in the absence of detailed histological reports on many of the cases this cannot be confirmed or refuted. Nevertheless, in a large proportion of cases nephrectomy and chemotherapy together evidently constitute sufficient treatment for the cure of infants with nephroblastoma. In the very youngest babies and some older patients nephrectomy alone has been followed by long-term disease-free survival.
Introduction
Studies on the use of purified fibre preparations in treating diabetes have often prompted comments unsupported by fact that using natural foods may be an effective and more palatable approach to this problem.1 2 To identify such foods 50-g carbohydrate portions of a wide range of foods were taken by groups of nealthy volunteers and the effect on the blood glucose response noted.3 These foods were then divided into two groups according to whether they caused small or large rises in blood glucose concentration. Foods were selected from each group and taken as breakfasts by diabetic volunteers so that their effects on blood glucose concentration could be studied and compared with the effect of a purified fibre product, guar crispbread. We report here the results.
Methods
Six diabetics (four women, two men; mean age 43± SEM 5 years; 99±3% ideal body weight; five receiving insulin 16-60 U/day and one controlled by diet alone) who had previously participated in a study testing the effect of guar and high-fibre foods on diabetic control were interested in testing the effect on their own blood glucose concentrations of taking meals of different composition and comparing this with the effect of guar. The food used had in earlier studies resulted in either large or small postprandial blood glucose responses in normal volunteers.3
The group met regularly on one or two Saturday mornings each month over four and a half months to test breakfasts in which a carbohydrate content equivalent to each subject's normal breakfast was derived from the following: wholemeal bread (88 ± SEM 13 g); wholemeal bread (46±8 g) and guar crispbreads (7±1 crispbread); wholemeal bread (46 ±8 g) and soya beans (91 ± 11 g); guar crispbread (7 ± 1 crispbreads) and soya beans (96 ± 18 g); soya beans (75 ±6g) and lentils (41±8 g); cornflakes (22±5 g) and wholemeal bread (45 ± 10 g); or porridge oats (26±6 g) and wholemeal spaghetti (27±6 g).
